Seeing Is Believing
Currently out of the existing stock ratings of Brian Abrahams, 264 are a HOLD (39.58%), 399 are a BUY (59.82%), 4 are a SELL (0.6%).
Analyst Brian Abrahams, currently employed at RBC, carries an average stock price target met ratio of 44.05% that have a potential upside of 31.71% achieved within 216 days.
Brian Abrahams’s has documented 1,295 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on HOOK, Hookipa Pharma at 15-Nov-2024.
Analyst best performing recommendations are on CNST (CONSTELLATION PHARMACEUTICALS).
The best stock recommendation documented was for CNST (CONSTELLATION PHARMACEUTICALS) at 10/10/2019. The price target of $20 was fulfilled within 27 days with a profit of $11.9 (146.91%) receiving and performance score of 54.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$13.39 (831.68%)
$15
2 months 21 days ago
(30-Aug-2024)
0/6 (0%)
$13.7 (1053.85%)
Buy
$9
$7.39 (459.01%)
1 years 6 months 8 days ago
(12-May-2023)
0/3 (0%)
$7.1 (373.68%)
Buy
1 years 7 months 24 days ago
(27-Mar-2023)
0/1 (0%)
$17.08 (114.48%)
Buy
$28
2 years 7 months 19 days ago
(01-Apr-2022)
0/2 (0%)
$16.83 (150.67%)
Hold
$9
$7.39 (459.01%)
$17
2 years 7 months 20 days ago
(31-Mar-2022)
0/3 (0%)
$3.91 (76.82%)
Which stock is Brian Abrahams is most bullish on?
Which stock is Brian Abrahams is most reserved on?
What Year was the first public recommendation made by Brian Abrahams?